A Tool Integrated into the Electronic Health Record to Guide Proper Decision-Making Regarding Peri-Endoscopic Anticoagulant Management: A Retrospective Cohort Study
- 1Department of Internal Medicine, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 2Department of Gastro-Enterology, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 3Department of Research Internal Medicine, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 4Department of Quality & Patient Safety, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 5Department of ICT Application Management, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 6Department of Hematology, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
- 0Department of Internal Medicine, Red Cross Hospital, Vondellaan 13, 1942 LE Beverwijk, The Netherlands.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new electronic health record tool aids decisions on anticoagulant management during endoscopic procedures. The tool was used correctly in 89% of cases, with low rates of bleeding and thromboembolic events observed.
Area Of Science
- Medical Informatics
- Clinical Decision Support Systems
- Pharmacology
Background
- Anticoagulants like VKAs and DOACs require careful management during endoscopic procedures to balance bleeding and thromboembolic risks.
- Peri-endoscopic management decisions involve stopping anticoagulants and potential bridging therapy.
- An electronic health record (EHR) tool was developed to assist in these complex decisions.
Purpose Of The Study
- To assess the proper utilization of an EHR-integrated decision-making tool for peri-endoscopic anticoagulant management.
- To evaluate the incidence of bleeding and thromboembolic events following the tool's implementation.
Main Methods
- Retrospective study of endoscopies performed between 2018 and 2021.
- Included patients on Vitamin-K antagonists (VKA) or direct oral anticoagulants (DOAC).
- Analysis of tool usage accuracy and event rates.
Main Results
- 986 endoscopies were analyzed; 89% of tool uses were correct.
- The primary error was incorrect bleeding risk selection (7.5%).
- Low cumulative incidence of bleeding (0.5% for DOAC, 0% for VKA) and thromboembolic events (0.2% for each).
Conclusions
- The EHR-integrated tool aids peri-endoscopic anticoagulant management.
- Analysis identified areas for tool improvement.
- Thromboembolic and major bleeding risks were low in the studied cohort.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:30
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:26
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

